A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedis

Mycoses

Volumn 49, Issue 3, 2006, Pages 236-241

  Watanabe, Shinichi ^a   Takahashi, Hisashi ^a   Nishikawa, Takeji ^b   Takiuchi, Iwao ^c   Higashi, Nobuhiko ^d   Nishimoto, Katsutaro ^e   Kagawa, Saburo ^f   Yamaguchi, Hideyo ^a   Ogawa, Hideoki ^g  

^a TEIKYO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d SAKAI MUNICIPAL HOSPITAL   (Japan)

^e Nagasaki Municipal Hospital   (Japan)

^f SHOWA UNIVERSITY   (Japan)

^g JUNTENDO UNIVERSITY   (Japan)

Author keywords

Luliconazole; New antimycotic; Phase III comparative clinical study

Indexed keywords

[4 (2,4 DICHLOROPHENYL) 1,3 DITHIOLAN 2 YLIDENE](1 IMIDAZOLYL)ACETONITRILE; ANTIFUNGAL AGENT; BIFONAZOLE; LULICONAZOLE; NEW DRUG; PR 2699; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FUNGUS CULTURE; HUMAN; HYPERTHERMIA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SKIN HOTNESS; SKIN INFLAMMATION; SKIN IRRITATION; SYMPTOM SCORE; SYMPTOMATOLOGY; TINEA PEDIS;

ADULT; AGED; ANTIFUNGAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; OINTMENTS; TINEA PEDIS; TREATMENT OUTCOME; TRICHOPHYTON;

FUNGI;

EID: 33646253449     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01218.x     Document Type: Article

References (14)

1. Stettendorf S. Tolerability and efficacy of bifonazole in dermatomycoses Arzneim Forsch/Drug Res 1983 33 750 4
2. Petranyi G Ryder NS Stitz A. Allylamine derivatives; new class of synthetic antifungal agents inhibiting fungal squalene epoxidase Science 1984 224 1239 41
3. Arika T Yokoo M Hase T Maeda T Amemia K Yamaguti H. Effects of butenafine hydrochloride. A new benzylamine derivative, on experimental dermatophytosis in guinea pig Antimicrob Agents Chemother 1990 34 2250 3
4. Ohmi T Konaka S Uchida M Yamaguchi H. Antifungal activity of the new agent lanoconazole in two tinea models Arzneim Forsch/Drug Res 1991 41 847 51
5. Epidemiological Investigation Committee for Human Mycoses in the Japanese Society for Medical Mycology (Co-chairman and reporter:Kasai T.) 1997 Epidemiological survey of dermatophytoses in Japan Jpn J Med Mycol 2001 42 11 8
6. Watanabe S. Present state and future direction of topical antifungals Jpn J Med Mycol 1999 40 151 5
7. Niwano Y Kuzuhara N Kodama H Yoshida M Miyazaki T Yamaguchi H. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imizazole antimycotic agent Antimicrob Agents Chemothr 1998 42 967 70
8. Uchida K Tanaka T Yamaguchi H. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis Micobiol Immunol 2003 47 143 6
9. Wagner W Reckers-Czaschka R. Oxiconazole in dermatomysosis - a double-blind, randomized therapy study to compare with bifonazole Mycoses 1987 30 484 92
10. Kagawa S Takahashi S Takahashi H Nishikawa T Watanabe S. SS717 Clinical Research Group. Clinical evaluation of SS717 cream in the treatment of dermatomycosis - a randomized comparative study with bifonazole cream as a control Clin Rep 1991 25 415 46
11. Kagawa S Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis Clin Exp Dermatol 1989 14 114 5
12. Smith EB Graham JL Ulrich JA Topical clotrimazole in tinea pedis South Med J 1977 70 47 8
13. Lackner TE Clissold SP. Bifonazole; a review of its antimicrobial activity and therapeutic use in superficial mycoses Drugs 1989 38 204 25
14. Suschka S Fladung B Merk HF. Clinical comparison of the efficacy and tolerability of once-daily Canestin with twice-daily Nisoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis Mycoses 2002 45 91 6